NIH Clinical Trial of Remdesivir to Treat COVID-19 Begins
February 26, 2020
February 26, 2020
WASHINGTON, Feb. 26 -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release:
* * *
- Study Enrolling Hospitalized Adults with COVID-19 in Nebraska
* * *
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the . . .
* * *
- Study Enrolling Hospitalized Adults with COVID-19 in Nebraska
* * *
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the . . .